Viewing Study NCT05564650


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-27 @ 5:25 AM
Study NCT ID: NCT05564650
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-08
First Post: 2022-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome
Sponsor: Thomas Jefferson University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module